Winquist E - Search Results

1

Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.

Izawa JI, Chin JL, Winquist E. Izawa JI, et al. Among authors: winquist e. Can J Urol. 2006 Jun;13 Suppl 3:48-53. Can J Urol. 2006. PMID: 16818012 Review.

2

Palliative chemoirradiation for transitional carcinoma of the bladder: a case report.

Greenland JD, Bauman GS, Winquist E, Shepherd RR. Greenland JD, et al. Among authors: winquist e. Can J Urol. 2000 Aug;7(4):1085-7. Can J Urol. 2000. PMID: 11109080

3

Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.

Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group. Segal R, et al. Among authors: winquist e. Can J Urol. 2002 Oct;9(5):1625-33. Can J Urol. 2002. PMID: 12431323

4

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis.

Winquist E, Kirchner TS, Segal R, Chin J, Lukka H; Genitourinary Cancer Disease Site Group, Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative. Winquist E, et al. J Urol. 2004 Feb;171(2 Pt 1):561-9. doi: 10.1097/01.ju.0000090967.08622.33. J Urol. 2004. PMID: 14713760 Review.

5

A 3-week gemcitabine-cisplatin regimen for metastatic urothelial cancer.

Winquist E, Wilson JJ, Dorreen M, Wong R, Jonker D, Iscoe N. Winquist E, et al. Can J Urol. 2004 Dec;11(6):2445-9. Can J Urol. 2004. PMID: 15636670 Clinical Trial.

6

A pilot study of regional participation in a videoconferenced multidisciplinary genitourinary tumor board.

Bauman G, Winquist E, Chin J. Bauman G, et al. Among authors: winquist e. Can J Urol. 2005 Feb;12(1):2532-6. Can J Urol. 2005. PMID: 15777490

7

Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.

Ernst DS, Brasher P, Venner PM, Czaykowski P, Moore MJ, Reyno L, Winquist E, Segal R, Hao D. Ernst DS, et al. Among authors: winquist e. Can J Urol. 2005 Apr;12(2):2575-80. Can J Urol. 2005. PMID: 15877938

8

A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer.

Winquist E, Moore MJ, Chi KN, Ernst DS, Hirte H, North S, Powers J, Walsh W, Boucher T, Patton R, Seymour L. Winquist E, et al. Urol Oncol. 2005 May-Jun;23(3):143-9. doi: 10.1016/j.urolonc.2004.12.012. Urol Oncol. 2005. PMID: 15907712 Clinical Trial.

9

Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder.

Ang C, Chambers AF, Tuck AB, Winquist E, Izawa JI. Ang C, et al. Among authors: winquist e. BJU Int. 2005 Oct;96(6):803-5. doi: 10.1111/j.1464-410X.2005.05716.x. BJU Int. 2005. PMID: 16153205

10

Chemotherapy for non-hormone refractory prostate cancer.

Winquist E. Winquist E. Can J Urol. 2006 Feb;13 Suppl 1:67-70. Can J Urol. 2006. PMID: 16526986 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters